Stock JAGX JAGUAR HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Jaguar Health, Inc.

Equities

JAGX

US47010C7065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.17 USD +0.06% Intraday chart for Jaguar Health, Inc. -4.01% +12.29%
Apr. 19 Venture Life renews revolving credit facility with Santander and HSBC AN
Apr. 18 Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society Congress in Support of Company's Expanding Focus on Cancer Supportive Care
AQ
Jaguar Health Appoints Biopharmaceutical Industry Veteran to Execute Company's In-licensing Growth Strategy in the Areas of Cancer and GI Supportive Care
AQ
Venture Life renews revolving credit facility with Santander and HSBC
AN
Jaguar Health, Inc. Appoints Catherine Miller Collis to the Role of Senior Vice President of Growth Strategy
CI
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
AQ
Wall Street Set to Open Sharply Lower Wednesday as Inflation Rises More Than Expected
MT
Exchange-Traded Funds Down, Equity Futures Higher Pre-Bell Wednesday Ahead of Fed Meeting Minutes
MT
Top Premarket Gainers
MT
Jaguar Health Granted Extension until August 13, 2024, to Regain Compliance with Nasdaq's Bid Price Requirement
AQ
Jaguar Health : Corporate Presentation – April 1, 2024
PU
Jaguar Health, Inc. Appoints Massimo Radaelli, PhD, as President of Jaguar International
CI
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
AQ
Jaguar Health Reports 2023 Financial Results
AQ
Transcript : Jaguar Health, Inc., Q4 2023 Earnings Call, Apr 01, 2024
Jaguar Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials and Corporate Updates
AQ
Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance
AQ
Jaguar Health Reaches Agreement With FDA on Design, Conduct of Medicine Study
MT
Jaguar Health, Inc. Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea in Dogs
CI
Jaguar Health Donates Supply of Mytesi to Humanitarian Aid Organization Direct Relief
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JAGX Stock
  4. News Jaguar Health, Inc.